T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Match Group
MTCH
|
+$3.31B |
| 2 |
Nike
NKE
|
+$2.27B |
| 3 |
FedEx
FDX
|
+$2.24B |
| 4 |
Bank of America
BAC
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.64B |
Top Sells
| 1 |
IAC Inc
IAC
|
+$3.91B |
| 2 |
Fortive
FTV
|
+$2.68B |
| 3 |
Alibaba
BABA
|
+$1.51B |
| 4 |
Linde
LIN
|
+$1.51B |
| 5 |
Willis Towers Watson
WTW
|
+$1.16B |
Sector Composition
| 1 | Technology | 25.65% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.89% |
| 4 | Financials | 11.37% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Adverum Biotechnologies
ADVM
$63.4M
| $10.9M | ﹤0.01% |
105,513
-106,952
| -50% | -$11M |
|
1277
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.78B
| $10.8M | ﹤0.01% |
+256,880
| New | +$10.8M |
|
|
FLIR
1278
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $10.8M | ﹤0.01% |
301,034
-15,664
| -5% | -$562K |
|
1279
Sixth Street Specialty
TSLX
$2.32B
| $10.8M | ﹤0.01% |
625,000
| – | – |
|
|
ELAT
1280
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $10.7M | ﹤0.01% |
241,674
-55,095
| -19% | -$2.43M |
|
|
RAVN
1281
DELISTED
Raven Industries Inc
RAVN
| $10.7M | ﹤0.01% |
495,534
| – | – |
|
1282
Genpact
G
$7.41B
| $10.7M | ﹤0.01% |
273,702
-3,802
| -1% | -$148K |
|
|
EIDX
1283
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $10.7M | ﹤0.01% |
210,757
-25,393
| -11% | -$1.28M |
|
1284
Essential Utilities
WTRG
$10.7B
| $10.6M | ﹤0.01% |
262,852
-48,326
| -16% | -$1.95M |
|
1285
Hubbell
HUBB
$23.2B
| $10.5M | ﹤0.01% |
76,870
-84,786
| -52% | -$11.6M |
|
1286
STRATTEC Security
STRT
$283M
| $10.5M | ﹤0.01% |
526,981
| – | – |
|
|
LDL
1287
DELISTED
Lydall, Inc.
LDL
| $10.3M | ﹤0.01% |
625,696
+1,700
| +0.3% | +$28.1K |
|
1288
Leggett & Platt
LEG
$1.3B
| $10.3M | ﹤0.01% |
251,298
-9,362
| -4% | -$385K |
|
1289
Phibro Animal Health
PAHC
$1.61B
| $10.2M | ﹤0.01% |
587,801
+3,957
| +0.7% | +$68.9K |
|
1290
Chegg
CHGG
$167M
| $10.2M | ﹤0.01% |
143,018
+962
| +0.7% | +$68.7K |
|
1291
Dynatrace
DT
$14.8B
| $10.2M | ﹤0.01% |
247,881
-1,592
| -0.6% | -$65.3K |
|
1292
Assembly Biosciences
ASMB
$168M
| $10.2M | ﹤0.01% |
51,520
-5,241
| -9% | -$1.03M |
|
1293
Lincoln National
LNC
$7.99B
| $10.1M | ﹤0.01% |
323,339
-53,938
| -14% | -$1.69M |
|
1294
Vornado Realty Trust
VNO
$8.25B
| $10.1M | ﹤0.01% |
299,236
-290,567
| -49% | -$9.79M |
|
1295
Teck Resources
TECK
$20.5B
| $9.95M | ﹤0.01% |
714,513
+107,610
| +18% | +$1.5M |
|
1296
Dyne Therapeutics
DYN
$1.87B
| $9.92M | ﹤0.01% |
+491,471
| New | +$9.92M |
|
|
AIV
1297
Aimco
AIV
$1.07B
| $9.89M | ﹤0.01% |
2,201,716
-78,228
| -3% | -$351K |
|
1298
Replimune Group
REPL
$447M
| $9.81M | ﹤0.01% |
426,161
+38,822
| +10% | +$894K |
|
1299
Ichor Holdings
ICHR
$579M
| $9.77M | ﹤0.01% |
453,047
+6,042
| +1% | +$130K |
|
1300
Vistra
VST
$71.1B
| $9.76M | ﹤0.01% |
517,554
-19,299
| -4% | -$364K |
|